ANGIOTECH PHARMACEUTICALS INC: key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2012)
- $243.8M
- Net Income/Loss (FY2012)
- -$6.2M
- Total Assets (FY2012)
- $608.4M
- Total Equity (FY2012)
- $140.7M
- Cash Flows from Operating Activities (FY2012)
- $66.4M
Source: ANGIOTECH PHARMACEUTICALS INC 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
